This result implies that the combination of ANRIL and circANRIL expressions in PBMCs has significant potential to be a sensitive and reliable transcriptional biomarker that possibly has a higher diagnostic value for CAD. The gene discussed is CDKN2B-AS1; the disease is coronary artery disorder.